Randomized Controlled Trial
Copyright ©The Author(s) 2023.
World J Clin Cases. May 16, 2023; 11(14): 3238-3247
Published online May 16, 2023. doi: 10.12998/wjcc.v11.i14.3238
Table 1 Patient characteristics
Characteristics
Pharmaceutical group (n = 45)
Non-pharmaceutical group (n = 45)
t value
P value
Sex, n (%)0.6530.419
Male35 (77.78)38 (84.45)
Female10 (22.22)7 (15.55)
Age (yr, mean)6-18 (9.03 ± 1.78)6-18 (9.23 ± 1.65)0.5530.582
Duration of disease (mo, mean)11-35 (23.89 ± 1.77)11-37 (23.48 ± 2.13)0.9930.323
Wechsler intelligence score (score, mean)≥ 85 (90.23 ± 2.91)≥ 85 (90.37 ± 2.75)0.2350.815
School, n (%)0.7200.396
Urban39 (86.67)36 (80.00)
Non-urban6 (13.33)9 (20.00)